Fingerprint Dive into the research topics of 'Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)'. Together they form a unique fingerprint.
- Sort by
- Weight
- Alphabetically
Month-6 primary outcomes of the READ-3 study (Ranibizumab for Edema of the mAcula in Diabetes-Protocol 3 with high dose)
D. V. Do, Y. J. Sepah, D. Boyer, D. Callanan, R. Gallemore, M. Bennett, D. M. Marcus, L. Halperin, M. A. Sadiq, N. Rajagopalan, P. A. Campochiaro, Q. D. Nguyen
Research output: Contribution to journal › Article › peer-review
20
Scopus
citations